Select a relevant service

Measure therapeutic endpoints in cancer models using tumor cells transplanted from a donor of a different species.

Use a single animal species to create one or more disease models for cachexia.

Xenografts derived from oncological samples.

Measure therapeutic endpoints in animal models of angiogenesis.

Measure therapeutic endpoints in animal models of ovarian cancer.

Measure therapeutic endpoints in renal models of cancer.

Use a single animal species to create one or more disease models for metastatic cancer, hematopoiesis and anemia.

Use a single animal species to create one or more disease models for cachexia and spontaneous cancer.

Utilize the patient-derived xenograft for drug response profiling and biomarker discovery of immuno-oncology drug candidates.

Evaluate human-specific therapeutics for checkpoint inhibitors, including anti-human PD-1, anti-human PDL-1, and anti-human CTLA-4 antibodies.